Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C39 | ISIN: US5049221055 | Ticker-Symbol: N6B
Tradegate
12.05.26 | 18:48
220,00 Euro
+0,92 % +2,00
Branche
Sonstige Technologie
Aktienmarkt
S&P 500
1-Jahres-Chart
LABCORP HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LABCORP HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
216,00220,0010:16
216,00220,0007:30

Aktuelle News zur LABCORP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiLabcorp Holdings (LH) is Positioned to Benefit from Demographic Trends1
DiLabcorp expands Epic integration for diagnostic testing5
06.05.Here's Why Labcorp (LH) Is a Great 'Buy the Bottom' Stock Now2
04.05.LABCORP HOLDINGS INC. - 10-Q, Quarterly Report1
04.05.Do Options Traders Know Something About Labcorp Stock We Don't?2
30.04.Labcorp forecasts 2026 adjusted EPS of $17.70 to $18.35 while raising revenue growth outlook to 5% to 6.1%3
30.04.Labcorp Advances As AI Investments, Core Businesses Drive Growth2
30.04.Labcorp Q1 2026 slides: beats forecasts, raises full-year guidance3
LABCORP Aktie jetzt für 0€ handeln
30.04.Labcorp übertrifft Prognosen für Q1 2026 - Aktie legt zu2
30.04.Labcorp Holdings (LH) Q1 Earnings and Revenues Top Estimates5
30.04.Labcorp Holdings Inc. Bottom Line Climbs In Q1268WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH) announced a profit for its first quarter that Increases, from last yearThe company's earnings totaled $277.8 million, or $3.35 per share. This...
► Artikel lesen
30.04.Labcorp Holdings Inc: Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance208Results from Operations for first quarter 2026 versus first quarter 2025: Revenue: $3.54 billion vs. $3.35 billion, up 5.8% Diluted EPS: $3.35 vs. $2.52...
► Artikel lesen
30.04.LABCORP HOLDINGS INC. - 8-K, Current Report2
29.04.Labcorp Holdings Q1 2026 Earnings Preview6
22.04.Labcorp führt Diagnosetest für Eierstockkrebs-Therapie von Merck ein4
22.04.Labcorp launches diagnostic test for ovarian cancer treatment5
22.04.Labcorp Launches FDA-Approved Companion Diagnostic to Identify Patients with Ovarian Cancer Eligible for KEYTRUDA262BURLINGTON, N.C., April 22, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide...
► Artikel lesen
15.04.Labcorp launches FDA-cleared rapid fentanyl urine test2
15.04.Labcorp Launches FDA-Cleared Fentanyl Test Delivering Results in 10 Minutes203First FDA-cleared rapid fentanyl test of its kind made in the United States designed to help emergency department and hospital teams act quickly when every second...
► Artikel lesen
14.04.Labcorp Unites With AWS and Datavant on AI Platform to Accelerate Alzheimer's Research3
Weiter >>
97 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1